-
SF10432 Wildtype Primary GBM Female, 50
Dataset
EGAD00001006019
-
RNAseq data for EGAS00001004572
Dataset
EGAD00001006876
-
Dataset for gynecologic_cancer-RNA
Dataset
EGAD00001008856
-
Dataset for melanoma-RNA
Dataset
EGAD00001008858
-
Dataset for hematopoietic_malignancy-RNA
Dataset
EGAD00001008860
-
Dataset for soft_tissue_tumor-WHOLE_GENOME
Dataset
EGAD00001008900
-
Dataset for leiomyosarcoma-RNA
Dataset
EGAD00001008849
-
Multiregional single cell RNA sequencing of human renal cell carcinoma
Dataset
EGAD00001008030
-
A Risk Score Incorporating Low Pass Whole Genome Sequencing of Cell Free DNA from Patients Receiving CD19 CAR T-Cell Therapy for Large B-Cell Lymphoma
Study
EGAS00001006308
-
Foundation Medicine Binary Calls
Dataset
EGAD50000000709
-
Reference epigenome CKD27_C_Mesan_WGBS data generated from KEP study
Dataset
EGAD00001003471
-
Reference epigenome CKD23_C_Mesan_WGBS data generated from KEP study
Dataset
EGAD00001003468
-
Reference epigenome ADMSC04_smRNA-Seq data generated from KEP study
Dataset
EGAD00001003870
-
Reference epigenome KNIH008 WGBS data generated from KEP study
Dataset
EGAD00001002756
-
GRIDSS somatic sv vcfs for EGAS00001004572
Dataset
EGAD00001006906
-
Strelka somatic snv vcfs for EGAS00001004572
Dataset
EGAD00001006907
-
IPF Core Biopsy Study RNA-Seq Fastqs
Dataset
EGAD00001007568
-
Refractory Cancer (RC) Program
Study
phs002097
-
112 "KOREAN" never-smoker female adenocarcinoma exome-seq
Dataset
EGAD00001005126
-
Biomarker Data from KATHERINE: A Phase III Study of Adjuvant Trastuzumab Emtansine versus Trastuzumab in Patients with Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer
Study
EGAS00001006229
-
Time course acetalax bisacodyl treatment
Dataset
EGAD50000000875
-
BelCovid_2_genotype
Dataset
EGAD00010002179
-
GEN_COVID_genotype
Dataset
EGAD00010002177
-
Gene Expression Profiling for study EGAS00001004165
Dataset
EGAD00010001842
-
mtDNA-Roma
Dataset
EGAD00010001844